Table 1. Patient characteristics.
| Characteristics | Global (N=370) | BMI<25.0 (N=150) | BMI 25.0–29.9 (N=154) | BMI 30.0–34.9 (N=50) | BMI⩾35.0 (N=16) |
|---|---|---|---|---|---|
| Median age, years (range) | 60 (34–84) | 56 (34–78) | 62 (44–84) | 63 (48–78) | 57 (47–78) |
| Mean weight, kg (s.d.) | 68 (11) | 59 (6) | 70 (6) | 80 (8) | 95 (13) |
| Mean height, m (s.d.) | 1.61 (0.06) | 1.62 (0.06) | 1.61 (0.06) | 1.59 (0.06) | 1.57 (0.06) |
| Mean BMI, kg m−2 (s.d.) |
26.3 (4.4) |
22.4 (1.9) |
27.1 (1.4) |
31.7 (1.4) |
38.4 (3.7) |
|
Age,
N
(%) | |||||
| <50 | 37 (10) | 23 (15) | 9 (6) | 2 (4) | 3 (19) |
| 50–55 | 75 (20) | 41 (27) | 25 (16) | 5 (10) | 4 (25) |
| >55 | 258 (70) | 86 (57) | 120 (78) | 43 (86) | 9 (56) |
| Median Let duration, weeks (range) |
53 (6–218) |
52 (6–218) |
54 (6–197) |
52 (6–213) |
55 (6–187) |
|
Clinical trial,
N
(%) | |||||
| GIM4 | 194 (52) | 83 (55) | 79 (51) | 24 (48) | 8 (50) |
| GIM5 | 176 (48) | 67 (45) | 75 (49) | 26 (52) | 8 (50) |
Abbreviations: BMI=body mass index; GIM=Gruppo Italiano Mammella; Let=letrozole; N=number of patients; s.d.=standard deviation.